Daniel Rieger
7Patents
4h-index
52Co-inventors
56Inventor score
Filing activity: Mar 1, 2002 → Nov 1, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7109000B2 | Proteins and nucleic acids encoding same | Human Necessities | 6 | Expired |
| US6974684B2 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | Human Necessities | 6 | Expired |
| US7141549B2 | Proteins and nucleic acids encoding same | Human Necessities | 5 | Expired |
| US7253266B2 | Polypeptides of FGF-CX | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8303959B2 | Compositions and methods for detection of antibodies specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) | Emerging Cross-Sectional Technologies | 4 | Active |
| US8580272B2 | Compositions and methods for detection of antibodies specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) | Emerging Cross-Sectional Technologies | 2 | Active |
| US9120857B2 | Compositions and methods for detection of antibodies specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.